newsfilter
← Latest News
PR Newswire·

NeuroBo Pharmaceuticals Regains Compliance with Nasdaq Minimum Price Requirement

NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, announced that ...